— Know what they know.
Not Investment Advice
Also trades as: METROPOLIS.BO (BSE) · $vol 0M

METROPOLIS.NS NSE

Metropolis Healthcare Limited
1W: -1.7% 1M: +9.5% 3M: -72.8% YTD: -73.6% 1Y: -65.2% 3Y: -58.1% 5Y: -71.9%
₹518.50 ($5.42)
-10.30 (-1.95%)
 
Weekly Expected Move ±5.4%
₹476 ₹505 ₹534 ₹563 ₹591
NSE · Healthcare · Medical - Diagnostics & Research · Alpha Radar Buy · Power 55 · ₹109.6B mcap · 106M float · 0.460% daily turnover
Smart Money Score
Watch 0
Insider
Congress
ETF Holdings
Key Statistics
Market Cap₹109.6B ($1.1B)
52W Range400.4-600
Volume435,883
Avg Volume487,966
Beta0.79
Dividend₹2.00
Analyst Ratings
No analyst coverage
Company Info
CEOSurendran Chemmenkotil
Employees4,313
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2019-04-15
250-D, Udyog Bhavan
Mumbai 400030
IN
91 22 6258 2810
About Metropolis Healthcare Limited

Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, confirmation, and/or monitoring of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. As of March 31, 2022, it operated 171 clinical laboratories, 9,000 pick-up points, and 704 assisted referral centers. The company was founded in 1980 and is headquartered in Mumbai, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms